Chronic Lyme disease: in defense of the scientific enterprise

@article{Baker2010ChronicLD,
  title={Chronic Lyme disease: in defense of the scientific enterprise},
  author={Phillip J. Baker},
  journal={The FASEB Journal},
  year={2010},
  volume={24},
  pages={4175 - 4177}
}
  • P. Baker
  • Published 1 November 2010
  • Medicine
  • The FASEB Journal
There is no better example of a relentless attack on evidence‐based biomedical research and the integrity of outstanding scientists than that associated with the treatment of a poorly defined condition called “chronic Lyme disease.” Here, a scientifically naive general population, the lay press, and legislators, who in most instances are unable to evaluate and judge scientific evidence properly, have been misled by patient advocate groups to believe that extended antibiotic therapy is the best… Expand
View on Wiley
aldf.com
16 Citations
Background Citations
6

Topics from this paper

    16 Citations

    Citation Type

    Citation Type

    The Lyme disease chronicles, continued: Chronic Lyme disease: in defense of the patient enterprise
    In his attack on “Lyme disease activists” who have besmirched the “scientific enterprise,” Phillip Baker misrepresents the controversy over tick-borne diseases (1). His view of ruthless healthcare… Expand
    Lyme disease: The great controversy
    TLDR
    This strange story begins with the disease's original characterization in the USA in the early 1970s, when a surprising number of children in Lyme and Old Lyme, Connecticut, were diagnosed as having juvenile rheumatoid arthritis. Expand
    Hyperbaric Oxygen Therapy and Chronic Lyme Disease: The Controversy and the Evidence
    TLDR
    An HBOT registry for Lyme disease and CLD would be an important tool to better understand the number of patients treated and whether or not HBOT has a beneficial effect on this puzzling and controversial condition. Expand
    Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?
    • E. Hodžić
    • Biology, Medicine
    • Bosnian journal of basic medical sciences
    • 2015
    TLDR
    A number of host cytokines were up- or down-regulated in tissues of both shame- and antibiotic-treated mice in the absence of histopathology, indicating a lack of host response to the presence of antimicrobial tolerant/resistant spirochetes. Expand
    Lyme Disease in Humans
    Lyme disease (Lyme borreliosis) is a tick-borne, zoonosis of adults and children caused by genospecies of the Borrelia burgdorferi sensu lato complex. The ailment, widespread throughout the Northern… Expand
    Lyme disease.
    TLDR
    Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States and resolves in most patients after treatment with appropriate antimicrobials for 2 to 4 weeks. Expand
    Persistence of Non-Cultivable Borrelia burgdorferi Following Antibiotic Treatment : Critical Need for Further Research
    Lyme disease, caused by a number of closely related members of the Borrelia burgdorferi sensu lato family (B. burgdorferi sensu stricto in the United States) that are transmitted by closely related… Expand
    Lyme borreliosis in Europe.
    Despite improvements in prevention, diagnosis and treatment, Lyme borreliosis (LB) is still the most common arthropod-borne disease in temperate regions of the northern hemisphere, with risk of… Expand
    Evolving Perspectives on Lyme Borreliosis in Canada
    TLDR
    Ongoing surveys and historical records demonstrate that Borrelia-positive Ixodes species are regu-larly present in regions of Canada that have previously been considered to be outside of the ranges of these species in re-cent modeling efforts. Expand
    Is It Possible to Make a Correct Diagnosis of Lyme Disease on Symptoms Alone? Review of Key Issues and Public Health Implications.
    • P. Baker
    • Medicine
    • The American journal of medicine
    • 2019
    TLDR
    Evidence is provided to support the validity of two-tier testing for the laboratory diagnosis of Lyme disease and the public health consequences of failing to consider these issues are discussed. Expand
    ...
    1
    2
    ...

    References

    SHOWING 1-10 OF 24 REFERENCES
    “Chronic Lyme” and other medically unexplained syndromes
    • G. Weissmann
    • Medicine
    • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
    • 2007
    TLDR
    Last fall, Lyme disease, a tick-borne borreliosis, made headlines in the business world: “Lyme Disease Guidelines Focus of Antitrust Probe,” the attorney general of Connecticut threatened to invoke anti-trust laws against The Infectious Diseases Society of America, which issued a set of evidencebased guidelines. Expand
    Perspectives on "chronic Lyme disease".
    • P. Baker
    • Medicine
    • The American journal of medicine
    • 2008
    TLDR
    What is known from clinical research about Lyme disease and posttreatment Lyme disease syndrome is reviewed to assist both practicing physicians and lawmakers in making sound and safe decisions with respect to treatment. Expand
    Final report of the Lyme disease review panel of the Infectious Diseases Society of America.
    • P. Lantos, W. A. Charini, +5 authors C. Baker
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2010
    TLDR
    The Review Panel concluded that the recommendations contained in the 2006 guidelines were medically and scientifically justified on the basis of all of the available evidence and that no changes to the guidelines were necessary. Expand
    Lyme disease--current state of knowledge.
    TLDR
    The most frequent clinical manifestation of Borrelia infection is erythema migrans, followed by neuroborreliosis, arthritis, acrodermatitis chronica atrophicans, and lymphocytosis benigna cutis, and the outcome is favorable. Expand
    The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.
    TLDR
    These updated guidelines replace the previous treatment guidelines published in 2000 and list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease and provide a partial list of therapies to be avoided. Expand
    Misconceptions about Lyme Disease: Confusions Hiding behind Ill-Chosen Terminology
    • L. Sigal
    • Medicine
    • Annals of Internal Medicine
    • 2002
    TLDR
    A review of the terminology contributing to confusion about Lyme disease is needed, finding that chronic is a common clinical diagnosis in some geographic areas and is based on thinking that is at odds with scientifically validated findings. Expand
    Science, politics, and values: the politicization of professional practice guidelines.
    TLDR
    This case exemplifies the politicization of health policy and confuses the relative spheres inhabited by normative discourse and science, as medical science, and the patients who depend on it, is too important for political distortion. Expand
    Study and treatment of post Lyme disease (STOP-LD)
    TLDR
    Ceftriaxone therapy in patients with PLS with severe fatigue was associated with an improvement in fatigue but not with cognitive function or an experimental laboratory measure of infection in this study. Expand
    Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
    TLDR
    There is sufficient data to conclude that, in both adults and children, this nervous system infection responds well to penicillin, ceftriaxone, cefotaxime, and doxycycline, and there is no compelling evidence that prolonged treatment with antibiotics has any beneficial effect in post–Lyme syndrome. Expand
    Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.
    TLDR
    There is considerable impairment of health-related quality of life among patients with persistent symptoms despite previous antibiotic treatment for acute Lyme disease, and treatment with intravenous and oral antibiotics for 90 days did not improve symptoms more than placebo. Expand
    ...
    1
    2
    3
    ...